Publication: Ecancer Medicalscience

First reported 23 hours ago - Updated 52 mins ago - 1 reports

Study identifies potential drug combination for mantle cell lymphoma and chronic lymphocytic leukaemia

Using the molecularly targeted drug ibrutinib (Imbruvica) together with the investigational anticancer agent ABT-199 may improve outcomes for patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL), according to preclinical data ... [Published Ecancer Medicalscience - 23 hours ago]
First reported 13 hours ago - Updated 12 hours ago - 1 reports

The end of an era – Prof Veronesi appoints new head of the European Institute of Oncology

Professor Umberto Veronesi, the Scientific Director of the European Institute of Oncology (IEO) and pioneer of breast cancer prevention and treatment, today announced his successor.Professor Roberto Orecchia will become the new Scientific Director at ... [Published Ecancer Medicalscience - 13 hours ago]
First reported Sep 22 2014 - Updated 13 hours ago - 1 reports

Inhibitor of RNA polymerase I shows promise as potential treatment for acute myeloid leukaemia and multiple myeloma

The investigational drug CX-5461, which blocks the protein RNA polymerase I (Pol I), prolonged survival in mouse models of highly aggressive acute myeloid Eugenia (AML) and multiple myeloma, according to data presented at the American Association for ... [Published Ecancer Medicalscience - Sep 22 2014]
First reported Sep 22 2014 - Updated 22 hours ago - 1 reports

New type of targeted therapy shows promise in preclinical models of B-cell malignancy

An investigational, bacterial toxin-based therapy targeted to the protein CD38, which is found on the surface of many human blood cancer cells, including multiple myeloma cells, dramatically increased survival in mice bearing human tumour cells, according ... [Published Ecancer Medicalscience - Sep 22 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

High adolescent red meat intake increases pre-menopausal breast cancer risk

by ecancer reporter Clare SansomMost current dietary advice suggests that diets rich in red meat can be associated with adverse health consequences including an increased risk of some types of cancer.However, several large, reputable studies set up to ... [Published Ecancer Medicalscience - Sep 22 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Half of cancers diagnosed at late stage as report shows early diagnosis saves lives and could have the NHS money

A Cancer Research UK analysis has revealed that 46 per cent of cancers in England are diagnosed at an advanced stage, when they are harder to treat successfully.The figures come as a new report shows that if all areas diagnosed cancers as early as the ... [Published Ecancer Medicalscience - Sep 22 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Study finds a new approach to tackle drug resistance in haematologic malignancies

Treating haematologic malignancies upfront with a combination of drugs based on the vulnerabilities of tumours as they evolve may be a viable strategy to avoid drug resistance, according to data presented at the American Association for Cancer Research ... [Published Ecancer Medicalscience - Sep 22 2014]
Entities: Tumor, malignancy, Dasatinib
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Drugs approved to treat other cancer types may improve treatment outcome for a type of childhood leukemia

Tyrosine kinase inhibitors (TKIs) may improve treatment outcome for children and young adults with Ph-like acute lymphoblastic leukaemia (Ph-like ALL), a disease with dismal prognosis, according to data presented at the American Association for Cancer ... [Published Ecancer Medicalscience - Sep 22 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Fifteen new designated centres of integrated oncology and palliative care announced

Gaps in palliative care for cancer patients are revealed in new research to be presented later at the ESMO 2014 Congress in Madrid .The findings come as 15 oncology centres in Europe, Canada, South America and Africa are awarded the prestigious title ... [Published Ecancer Medicalscience - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Exercise boosts tumour-fighting ability of chemotherapy

Study after study has proven it true: exercise is good for you.But new research from University of Pennsylvania scientists suggests that exercise may have an added benefit for cancer patients undergoing chemotherapy.Their work, performed in a mouse model ... [Published Ecancer Medicalscience - Sep 19 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Enzalutamide may offer chemotherapy alternative in metastatic castration-resistant prostate cancer

The United States Food and Drug Association has approved the use of enzalutamide for patients with metastatic castration-resistant prostate cancer (CRPC).Enzalutamide is an androgen receptor inhibitor that is taken orally once a day.It was initially approved ... [Published Ecancer Medicalscience - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

FDA approves cologuard for colorectal cancer screening

The US Food and Drug Administration today approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be ... [Published Ecancer Medicalscience - Sep 18 2014]

Quotes

"But then when you get over that hump you have to deal with the long-term elevated risk of cardiovascular disease."
"Faecal blood testing is a well-established screening tool and the clinical data showed that the test detected more cancers than a commonly used faecal occult test.”"
"The result is a meaningful period of time during which men have their disease controlled without the need for chemotherapy."
"For patients that achieve a complete response, neck surgery is probably unnecessary" says Thomas J Galloway, MD, Attending Physician and Director of Clinical Research at Fox Chase and lead author on the study

More Content

All (64) | News (64) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
The end of an era – Prof Veronesi appoints new ... [Published Ecancer Medicalscience - 13 hours ago]
Study identifies potential drug combination for... [Published Ecancer Medicalscience - 23 hours ago]
New type of targeted therapy shows promise in p... [Published Ecancer Medicalscience - Sep 22 2014]
Study finds a new approach to tackle drug resis... [Published Ecancer Medicalscience - Sep 22 2014]
Inhibitor of RNA polymerase I shows promise as ... [Published Ecancer Medicalscience - Sep 22 2014]
Drugs approved to treat other cancer types may ... [Published Ecancer Medicalscience - Sep 22 2014]
High adolescent red meat intake increases pre-m... [Published Ecancer Medicalscience - Sep 22 2014]
Half of cancers diagnosed at late stage as repo... [Published Ecancer Medicalscience - Sep 22 2014]
Exercise boosts tumour-fighting ability of chem... [Published Ecancer Medicalscience - Sep 19 2014]
Fifteen new designated centres of integrated on... [Published Ecancer Medicalscience - Sep 19 2014]
FDA approves cologuard for colorectal cancer sc... [Published Ecancer Medicalscience - Sep 18 2014]
Enzalutamide may offer chemotherapy alternative... [Published Ecancer Medicalscience - Sep 18 2014]
NICE approves dabrafenib for BRAF V600 advanced... [Published Ecancer Medicalscience - Sep 18 2014]
Wild berry extract may strengthen effectiveness... [Published Ecancer Medicalscience - Sep 18 2014]
ASTRO: Many throat cancer patients can skip nec... [Published Ecancer Medicalscience - Sep 17 2014]
Case Report: Recurrent aggressive fibromatosis ... [Published Ecancer Medicalscience - Sep 16 2014]
Personalised medicine declared a 'priority' for... [Published Ecancer Medicalscience - Sep 11 2014]
Molecular study confirms 4 different HER2 brea... [Published Ecancer Medicalscience - Sep 10 2014]
The molecular mechanism behind elevated TGF-bet... [Published Ecancer Medicalscience - Sep 10 2014]
Conference Report: Lessons from the Fourth Metr... [Published Ecancer Medicalscience - Sep 09 2014]
Clinical trials group extols patient-centred ap... [Published Ecancer Medicalscience - Sep 09 2014]
Researchers find new gene mutations for Wilms T... [Published Ecancer Medicalscience - Sep 09 2014]
UV light can turn gene into source of skin canc... [Published Ecancer Medicalscience - Sep 09 2014]
Many patients in cancer centres may not experie... [Published Ecancer Medicalscience - Sep 08 2014]
Soya supplementation adversely effects expressi... [Published Ecancer Medicalscience - Sep 04 2014]
Moles on the skin increase skin cancer risk [Published Ecancer Medicalscience - Sep 04 2014]
Review: The most common nursing diagnosis among... [Published Ecancer Medicalscience - Sep 04 2014]
Soldiers placed at risk of skin cancer, study r... [Published Ecancer Medicalscience - Sep 03 2014]
One in ten doctors admits to using sunbeds [Published Ecancer Medicalscience - Sep 03 2014]
Response to neoadjuvant chemotherapy and tumour... [Published Ecancer Medicalscience - Sep 02 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.